PIPERACILLIN AND TAZOBACTAM

PIPERACILLIN AND TAZOBACTAM was reported 13064 times

PIPERACILLIN AND TAZOBACTAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DIABETIC MACROANGIOPATHY 9 0.2727
1 PYELONEPHRITIS FUNGAL 13 0.1757
2 COVID-19 TREATMENT 9 0.1324
3 NEW ONSET REFRACTORY STATUS EPILEPTICUS 10 0.0909
4 RETINITIS VIRAL 10 0.0826
5 PERINEPHRIC ABSCESS 12 0.0789
6 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 11 0.0775
7 GEOTRICHUM INFECTION 16 0.0758
8 GASTROINTESTINAL MUCORMYCOSIS 12 0.0719
9 EMPHYSEMATOUS PYELONEPHRITIS 12 0.0656
10 TRICHOSPORON INFECTION 26 0.0642
11 INTRA-ABDOMINAL PRESSURE INCREASED 10 0.0637
12 SPINAL MUSCULAR ATROPHY 17 0.0630
13 ALVEOLAR LUNG DISEASE 11 0.0579
14 PYROGLUTAMIC ACIDOSIS 22 0.0554
15 ACID BASE BALANCE ABNORMAL 12 0.0536
16 CHOROIDITIS 20 0.0535
17 PORTAL FIBROSIS 11 0.0514
18 URINARY TRACT CANDIDIASIS 9 0.0471
19 LINEAR IGA DISEASE 77 0.0462
20 DEHISCENCE 8 0.0423
21 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 17 0.0419
22 DISSEMINATED MUCORMYCOSIS 16 0.0406
23 CLOSTRIDIUM TEST POSITIVE 88 0.0399
24 STOMA CLOSURE 12 0.0386
25 EXTRAVASATION BLOOD 9 0.0378
26 RHINOCEREBRAL MUCORMYCOSIS 13 0.0375
27 PNEUMOCOCCAL SEPSIS 24 0.0365
28 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 11 0.0356
29 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 29 0.0353
30 NECROSIS ISCHAEMIC 16 0.0347
31 POSITIVE AIRWAY PRESSURE THERAPY 10 0.0342
32 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 13 0.0342
33 SYSTEMIC CANDIDA 78 0.0310
34 CITROBACTER INFECTION 13 0.0303
35 RESPIRATORY TRACT INFECTION BACTERIAL 15 0.0301
36 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 15 0.0294
37 PNEUMATOSIS 13 0.0291
38 ENTEROCOCCUS TEST POSITIVE 18 0.0278
39 ACANTHOSIS 9 0.0274
40 MOTOR NEURONE DISEASE 13 0.0267
41 RESPIRATORY TRACT INFECTION FUNGAL 14 0.0265
42 DEVICE RELATED BACTERAEMIA 8 0.0258
43 HYPERFERRITINAEMIA 11 0.0255
44 NEUTROPHILIC DERMATOSIS 10 0.0253
45 SERRATIA INFECTION 18 0.0242
46 GASTRODUODENAL ULCER 10 0.0238
47 PSEUDOMONAL BACTERAEMIA 20 0.0234
48 FUNGAEMIA 36 0.0229
49 CONGESTIVE HEPATOPATHY 10 0.0223
50 CANDIDA SEPSIS 20 0.0223
51 VESICOURETERIC REFLUX 9 0.0222
52 ABDOMINAL COMPARTMENT SYNDROME 14 0.0220
53 EOSINOPHILIC PNEUMONIA ACUTE 19 0.0219
54 ACINETOBACTER INFECTION 24 0.0219
55 MUCORMYCOSIS 56 0.0215
56 FUSARIUM INFECTION 15 0.0214
57 DELAYED GRAFT FUNCTION 15 0.0211
58 TRACHEOBRONCHITIS 16 0.0208
59 COAGULATION TEST ABNORMAL 16 0.0208
60 MEGACOLON 32 0.0204
61 PNEUMONIA NECROTISING 13 0.0201
62 STRONGYLOIDIASIS 32 0.0198
63 JARISCH-HERXHEIMER REACTION 14 0.0197
64 CEREBRAL ASPERGILLOSIS 12 0.0195
65 DYSBIOSIS 16 0.0195
66 ENDOMETRIAL DISORDER 8 0.0194
67 ANAEMIA HAEMOLYTIC AUTOIMMUNE 16 0.0193
68 CANDIDA TEST POSITIVE 8 0.0191
69 NEUTROPENIC INFECTION 17 0.0178
70 PATHOGEN RESISTANCE 160 0.0175
71 DIFFUSE ALVEOLAR DAMAGE 20 0.0174
72 URINARY TRACT INFECTION ENTEROCOCCAL 16 0.0171
73 PULMONARY MUCORMYCOSIS 9 0.0170
74 PSEUDOMEMBRANOUS COLITIS 38 0.0170
75 SCEDOSPORIUM INFECTION 12 0.0170
76 PULMONARY NOCARDIOSIS 14 0.0170
77 DISSEMINATED ASPERGILLOSIS 8 0.0169
78 CRYSTAL NEPHROPATHY 10 0.0169
79 APLASTIC ANAEMIA 87 0.0166
80 BRONCHOPULMONARY ASPERGILLOSIS 129 0.0166
81 LARGE INTESTINE INFECTION 20 0.0163
82 RENAL TUBULAR NECROSIS 156 0.0159
83 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 409 0.0159
84 KOUNIS SYNDROME 36 0.0158
85 SJS-TEN OVERLAP 11 0.0157
86 RASH MORBILLIFORM 42 0.0151
87 SUPERINFECTION BACTERIAL 12 0.0151
88 ASPERGILLUS INFECTION 98 0.0149
89 PERFORATION 12 0.0149
90 ENTEROBACTER INFECTION 25 0.0149
91 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 16 0.0145
92 LUNG CONSOLIDATION 40 0.0143
93 CLOSTRIDIUM DIFFICILE COLITIS 150 0.0141
94 TOXIC EPIDERMAL NECROLYSIS 211 0.0139
95 ISCHAEMIC CEREBRAL INFARCTION 16 0.0138
96 ENTEROCOCCAL INFECTION 66 0.0136
97 RED MAN SYNDROME 12 0.0136
98 PROCALCITONIN INCREASED 16 0.0136
99 DIFFERENTIATION SYNDROME 10 0.0136
100 STENOTROPHOMONAS INFECTION 18 0.0133
101 DIARRHOEA INFECTIOUS 10 0.0127
102 RESUSCITATION 21 0.0127
103 KLEBSIELLA INFECTION 64 0.0126
104 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 41 0.0126
105 HAEMOPERITONEUM 10 0.0125
106 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 97 0.0125
107 HERPES ZOSTER DISSEMINATED 10 0.0125
108 EOSINOPHILIA 217 0.0124
109 LYMPHADENECTOMY 12 0.0123
110 NEPHROPATHY TOXIC 138 0.0123
111 DRUG CLEARANCE DECREASED 16 0.0122
112 FUNGAL SEPSIS 10 0.0120
113 INFECTIOUS PLEURAL EFFUSION 18 0.0118
114 TRACHEITIS 9 0.0118
115 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 45 0.0118
116 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 86 0.0114
117 STAPHYLOCOCCUS TEST POSITIVE 24 0.0114
118 MULTIPLE ORGAN DYSFUNCTION SYNDROME 322 0.0114
119 THERAPEUTIC PRODUCT CROSS-REACTIVITY 10 0.0112
120 HYPOFIBRINOGENAEMIA 11 0.0111
121 STREPTOCOCCAL BACTERAEMIA 12 0.0110
122 SKIN OEDEMA 11 0.0110
123 RASH MACULO-PAPULAR 241 0.0108
124 PNEUMOMEDIASTINUM 19 0.0105
125 INTESTINAL ISCHAEMIA 57 0.0103
126 CLOSTRIDIAL INFECTION 35 0.0103
127 SYSTEMIC MYCOSIS 12 0.0103
128 SPUTUM INCREASED 22 0.0102
129 SEPTIC SHOCK 441 0.0101
130 PSEUDOMONAS INFECTION 86 0.0100
131 OLIGURIA 62 0.0100
132 TUBULOINTERSTITIAL NEPHRITIS 187 0.0100
133 DIABETES INSIPIDUS 24 0.0100
134 ENTEROCOCCAL SEPSIS 8 0.0099
135 CRYPTOCOCCOSIS 16 0.0098
136 PNEUMONIA PSEUDOMONAL 15 0.0098
137 INCREASED BRONCHIAL SECRETION 25 0.0098
138 HAEMODYNAMIC INSTABILITY 74 0.0097
139 PNEUMONIA FUNGAL 38 0.0096
140 LIVEDO RETICULARIS 20 0.0096
141 EMPYEMA 19 0.0095
142 HYPOPERFUSION 10 0.0095
143 KLEBSIELLA BACTERAEMIA 9 0.0095
144 NECROTISING COLITIS 12 0.0095
145 ESCHERICHIA INFECTION 77 0.0094
146 FEBRILE INFECTION 11 0.0093
147 PNEUMONIA KLEBSIELLA 17 0.0092
148 HYPERNATRAEMIA 46 0.0092
149 RESPIRATORY ALKALOSIS 15 0.0092
150 PNEUMOPERITONEUM 17 0.0092
151 CONTINUOUS HAEMODIAFILTRATION 9 0.0092
152 MENINGITIS CRYPTOCOCCAL 16 0.0091
153 VASOPLEGIA SYNDROME 15 0.0091
154 PSEUDOMONAL SEPSIS 16 0.0091
155 BRONCHIAL DISORDER 14 0.0090
156 MECHANICAL VENTILATION 17 0.0089
157 RESPIRATORY ACIDOSIS 35 0.0089
158 PERIPHERAL SENSORIMOTOR NEUROPATHY 11 0.0088
159 PELVIC ABSCESS 10 0.0087
160 ACUTE RESPIRATORY DISTRESS SYNDROME 154 0.0087
161 NEUTROPENIC COLITIS 18 0.0087
162 APLASIA 17 0.0087
163 FOLATE DEFICIENCY 10 0.0087
164 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 8 0.0086
165 IMMUNE THROMBOCYTOPENIA 39 0.0085
166 CHEST X-RAY ABNORMAL 26 0.0085
167 CLOSTRIDIUM DIFFICILE INFECTION 184 0.0084
168 CYTOMEGALOVIRUS TEST POSITIVE 15 0.0084
169 EOSINOPHILIC PNEUMONIA 26 0.0082
170 HYPOCOAGULABLE STATE 8 0.0082
171 HYPERLACTACIDAEMIA 22 0.0082
172 SOFT TISSUE INFECTION 15 0.0082
173 HYPERTRANSAMINASAEMIA 57 0.0082
174 NOSOCOMIAL INFECTION 18 0.0082
175 OTOTOXICITY 15 0.0081
176 MULTIPLE-DRUG RESISTANCE 25 0.0081
177 CHOLESTASIS 154 0.0080
178 KLEBSIELLA SEPSIS 9 0.0080
179 HUMAN HERPESVIRUS 6 INFECTION 15 0.0079
180 CYTOMEGALOVIRUS INFECTION REACTIVATION 35 0.0079
181 INFECTION REACTIVATION 9 0.0079
182 HEPATITIS CHOLESTATIC 47 0.0078
183 HEPATITIS FULMINANT 23 0.0077
184 LIVER ABSCESS 25 0.0077
185 AGRANULOCYTOSIS 143 0.0077
186 CUTANEOUS VASCULITIS 28 0.0077
187 TOXIC SKIN ERUPTION 77 0.0076
188 CHOLESTATIC LIVER INJURY 17 0.0076
189 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 45 0.0076
190 CANDIDA INFECTION 128 0.0076
191 PULMONARY SEPSIS 11 0.0076
192 HISTOPLASMOSIS DISSEMINATED 12 0.0076
193 ENTEROCOCCAL BACTERAEMIA 8 0.0075
194 PNEUMOCYSTIS JIROVECII INFECTION 9 0.0075
195 DEVICE RELATED SEPSIS 15 0.0074
196 STAPHYLOCOCCAL BACTERAEMIA 32 0.0074
197 TYPE IV HYPERSENSITIVITY REACTION 20 0.0073
198 INFLAMMATORY MARKER INCREASED 36 0.0073
199 PNEUMONIA CYTOMEGALOVIRAL 14 0.0072
200 HYPERAMMONAEMIA 36 0.0072
201 BACTERIAL SEPSIS 23 0.0071
202 CELL DEATH 14 0.0071
203 PLATELET TRANSFUSION 9 0.0070
204 MIXED LIVER INJURY 21 0.0070
205 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 23 0.0070
206 DRUG RESISTANCE 178 0.0069
207 ASPERGILLOSIS 9 0.0069
208 PNEUMONIA LEGIONELLA 11 0.0069
209 BACTERAEMIA 81 0.0068
210 INCISION SITE PAIN 8 0.0068
211 ESCHERICHIA BACTERAEMIA 16 0.0068
212 TACHYPNOEA 92 0.0068
213 INTESTINAL DILATATION 9 0.0067
214 TRANSPLANT REJECTION 54 0.0067
215 AUTOIMMUNE HAEMOLYTIC ANAEMIA 23 0.0067
216 GASTROINTESTINAL WALL THICKENING 10 0.0067
217 HEPATOCELLULAR INJURY 94 0.0066
218 PYELONEPHRITIS ACUTE 13 0.0066
219 ACUTE KIDNEY INJURY 1014 0.0066
220 FEBRILE BONE MARROW APLASIA 28 0.0066
221 NEPHRITIS 22 0.0066
222 THROMBOCYTOSIS 24 0.0065
223 MYOGLOBIN BLOOD INCREASED 10 0.0065
224 HISTIOCYTOSIS HAEMATOPHAGIC 19 0.0064
225 CEREBELLAR SYNDROME 14 0.0064
226 HEPATIC NECROSIS 24 0.0064
227 CYTOLYTIC HEPATITIS 21 0.0063
228 COMPLICATIONS OF TRANSPLANTED KIDNEY 14 0.0062
229 LEUKOCYTOSIS 111 0.0061
230 TOXIC ENCEPHALOPATHY 31 0.0061
231 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 13 0.0061
232 DRUG LEVEL INCREASED 101 0.0061
233 LUNG OPACITY 16 0.0061
234 PULMONARY ALVEOLAR HAEMORRHAGE 34 0.0061
235 HYPOVOLAEMIC SHOCK 29 0.0060
236 STEVENS-JOHNSON SYNDROME 134 0.0060
237 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 30 0.0060
238 CYTOMEGALOVIRUS INFECTION 100 0.0060
239 PNEUMATOSIS INTESTINALIS 17 0.0060
240 PERICARDIAL HAEMORRHAGE 13 0.0059
241 ANURIA 51 0.0059
242 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 13 0.0059
243 CYTOKINE RELEASE SYNDROME 118 0.0059
244 CIRCULATORY COLLAPSE 99 0.0058
245 CAPILLARY LEAK SYNDROME 12 0.0058
246 DERMATITIS EXFOLIATIVE 29 0.0058
247 VARICELLA ZOSTER VIRUS INFECTION 12 0.0058
248 EXTREMITY NECROSIS 10 0.0057
249 ENDOTRACHEAL INTUBATION 16 0.0057
250 INTERMITTENT CLAUDICATION 9 0.0057
251 ACUTE RESPIRATORY FAILURE 109 0.0057
252 PNEUMONIA BACTERIAL 52 0.0057
253 HYPERCAPNIA 17 0.0056
254 METABOLIC ALKALOSIS 9 0.0056
255 ENCEPHALOPATHY 137 0.0056
256 PNEUMOCYSTIS JIROVECII PNEUMONIA 56 0.0056
257 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 53 0.0055
258 ACUTE HEPATIC FAILURE 75 0.0055
259 IMMUNE-MEDIATED LUNG DISEASE 10 0.0055
260 HEPARIN-INDUCED THROMBOCYTOPENIA 27 0.0055
261 LONG QT SYNDROME 13 0.0054
262 BLOOD CULTURE POSITIVE 16 0.0053
263 FEBRILE NEUTROPENIA 354 0.0053
264 DISSEMINATED INTRAVASCULAR COAGULATION 75 0.0053
265 LUNG INFILTRATION 47 0.0053
266 GLOMERULONEPHRITIS 13 0.0053
267 MYELOPATHY 10 0.0053
268 LUNG ABSCESS 11 0.0052
269 DISEASE COMPLICATION 24 0.0052
270 DRUG LEVEL ABOVE THERAPEUTIC 24 0.0052
271 APLASIA PURE RED CELL 18 0.0052
272 TORSADE DE POINTES 41 0.0052
273 CALCULUS URINARY 8 0.0052
274 NEUTROPENIC SEPSIS 37 0.0052
275 ATELECTASIS 50 0.0052
276 ADENOVIRUS INFECTION 15 0.0052
277 CHOLANGITIS 32 0.0052
278 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 12 0.0052
279 HYPERBILIRUBINAEMIA 53 0.0051
280 BLOOD PRESSURE DIASTOLIC ABNORMAL 13 0.0051
281 SUSPECTED OFF LABEL USE 23 0.0051
282 RESPIRATORY FAILURE 370 0.0051
283 VASCULAR DEVICE INFECTION 23 0.0051
284 PANCYTOPENIA 282 0.0050
285 RETROPERITONEAL HAEMATOMA 11 0.0050
286 FAECES PALE 11 0.0049
287 VENOOCCLUSIVE LIVER DISEASE 24 0.0049
288 CEREBRAL ISCHAEMIA 25 0.0049
289 DISTRIBUTIVE SHOCK 11 0.0049
290 GASTROINTESTINAL NECROSIS 14 0.0048
291 HYPOXIA 166 0.0047
292 ODYNOPHAGIA 28 0.0047
293 COAGULOPATHY 78 0.0047
294 SHOCK HAEMORRHAGIC 38 0.0047
295 METABOLIC ENCEPHALOPATHY 14 0.0047
296 LOSS OF EMPLOYMENT 14 0.0046
297 LARGE INTESTINE PERFORATION 32 0.0046
298 OXYGEN CONSUMPTION INCREASED 11 0.0046
299 KIDNEY TRANSPLANT REJECTION 22 0.0046
300 PNEUMONIA STAPHYLOCOCCAL 9 0.0046
301 UROSEPSIS 42 0.0045
302 BRAIN NATRIURETIC PEPTIDE INCREASED 14 0.0045
303 NECROTISING FASCIITIS 16 0.0045
304 ELECTROCARDIOGRAM T WAVE INVERSION 10 0.0045
305 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 12 0.0045
306 NEUROTOXICITY 79 0.0045
307 ENDOPHTHALMITIS 27 0.0045
308 HAEMOLYTIC ANAEMIA 40 0.0045
309 THROMBOCYTOPENIA 498 0.0044
310 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 11 0.0044
311 ACIDOSIS 34 0.0044
312 PERSECUTORY DELUSION 11 0.0044
313 PETECHIAE 46 0.0044
314 SHOCK 101 0.0044
315 CLONUS 12 0.0044
316 SERUM FERRITIN INCREASED 23 0.0044
317 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 12 0.0043
318 EOSINOPHIL COUNT INCREASED 36 0.0043
319 TUMOUR LYSIS SYNDROME 38 0.0043
320 HEPATOTOXICITY 96 0.0043
321 PULSELESS ELECTRICAL ACTIVITY 18 0.0043
322 NOCARDIOSIS 11 0.0043
323 ENDOCARDITIS 22 0.0043
324 HAEMOLYSIS 33 0.0043
325 SKIN NECROSIS 22 0.0042
326 PUSTULE 10 0.0042
327 DRUG-INDUCED LIVER INJURY 132 0.0042
328 HYPERSENSITIVITY VASCULITIS 11 0.0042
329 BONE MARROW FAILURE 84 0.0041
330 METABOLIC ACIDOSIS 132 0.0041
331 HENOCH-SCHONLEIN PURPURA 9 0.0041
332 MYCOBACTERIUM AVIUM COMPLEX INFECTION 11 0.0041
333 HAEMATOLOGICAL INFECTION 10 0.0041
334 ABDOMINAL ABSCESS 18 0.0041
335 HAEMODIALYSIS 34 0.0040
336 INTRAVENTRICULAR HAEMORRHAGE 10 0.0040
337 BRAIN HERNIATION 12 0.0040
338 DRUG ERUPTION 71 0.0040
339 TENOSYNOVITIS 11 0.0040
340 HEPATOMEGALY 39 0.0040
341 METABOLIC DISORDER 23 0.0040
342 NEONATAL RESPIRATORY DISTRESS SYNDROME 14 0.0040
343 GUILLAIN-BARRE SYNDROME 19 0.0039
344 RENAL TUBULAR DISORDER 11 0.0039
345 DISSEMINATED TUBERCULOSIS 10 0.0039
346 GENERALISED OEDEMA 48 0.0039
347 MUCOSAL INFLAMMATION 101 0.0039
348 HYPERVOLAEMIA 19 0.0038
349 PURPURA 34 0.0038
350 ORGANISING PNEUMONIA 19 0.0038
351 HEPATIC FAILURE 115 0.0038
352 ABSCESS 60 0.0038
353 MULTI-ORGAN FAILURE 65 0.0038
354 ARTERIOSPASM CORONARY 15 0.0037
355 HYPOALBUMINAEMIA 29 0.0037
356 SEPSIS 413 0.0037
357 JAUNDICE CHOLESTATIC 13 0.0037
358 DEMYELINATION 15 0.0037
359 SUBDURAL HAEMORRHAGE 10 0.0037
360 SEROTONIN SYNDROME 70 0.0036
361 GRAFT VERSUS HOST DISEASE IN SKIN 8 0.0036
362 STATUS EPILEPTICUS 41 0.0036
363 RESPIRATORY DISTRESS 100 0.0036
364 BLOOD CREATINE INCREASED 16 0.0036
365 HYDRONEPHROSIS 27 0.0036
366 VENOOCCLUSIVE DISEASE 9 0.0036
367 SERUM SICKNESS 10 0.0036
368 BRAIN ABSCESS 9 0.0036
369 HYPERTHERMIA 27 0.0035
370 STAPHYLOCOCCAL INFECTION 116 0.0035
371 CYTOMEGALOVIRUS COLITIS 8 0.0035
372 LEUKOPENIA 174 0.0035
373 GRAFT VERSUS HOST DISEASE 25 0.0035
374 LYMPHOPENIA 49 0.0035
375 DELIRIUM 120 0.0035
376 DERMATITIS EXFOLIATIVE GENERALISED 12 0.0034
377 HAEMOTHORAX 10 0.0034
378 RALES 20 0.0034
379 MYOCLONUS 41 0.0034
380 RASH PUSTULAR 25 0.0034
381 BLOOD LACTIC ACID INCREASED 18 0.0034
382 SKIN EROSION 11 0.0034
383 ARTHRITIS BACTERIAL 14 0.0034
384 PNEUMOTHORAX 54 0.0034
385 STRIDOR 10 0.0034
386 ERYSIPELAS 17 0.0034
387 HAEMORRHAGIC DIATHESIS 12 0.0034
388 CARDIAC TAMPONADE 16 0.0034
389 CREPITATIONS 10 0.0034
390 NORMOCHROMIC NORMOCYTIC ANAEMIA 10 0.0033
391 PULMONARY HAEMORRHAGE 26 0.0033
392 HYPERPYREXIA 14 0.0033
393 HEPATIC CYTOLYSIS 42 0.0033
394 HEPATITIS 84 0.0033
395 LEFT VENTRICULAR HYPERTROPHY 14 0.0033
396 OESOPHAGEAL CANDIDIASIS 13 0.0033
397 BK VIRUS INFECTION 11 0.0033
398 PLEURAL EFFUSION 198 0.0033
399 HYPOPHOSPHATAEMIA 24 0.0032
400 ARTHRITIS INFECTIVE 15 0.0032
401 ASCITES 95 0.0032
402 HERPES SIMPLEX 21 0.0032
403 OCULAR ICTERUS 14 0.0032
404 BLOOD IMMUNOGLOBULIN G DECREASED 8 0.0032
405 DRUG INTERACTION 510 0.0032
406 WOUND COMPLICATION 11 0.0032
407 PNEUMONIA ASPIRATION 80 0.0032
408 PNEUMONITIS 87 0.0032
409 OXYGEN SATURATION ABNORMAL 9 0.0032
410 ILEUS PARALYTIC 14 0.0031
411 ABDOMINAL INFECTION 8 0.0031
412 ENTEROCOLITIS 18 0.0031
413 RASH VESICULAR 15 0.0031
414 THROMBOTIC MICROANGIOPATHY 30 0.0031
415 HYPOKALAEMIA 142 0.0031
416 ACUTE GRAFT VERSUS HOST DISEASE 14 0.0031
417 ESCHERICHIA URINARY TRACT INFECTION 13 0.0031
418 ISCHAEMIA 14 0.0030
419 UPPER GASTROINTESTINAL HAEMORRHAGE 51 0.0030
420 SINUS TACHYCARDIA 43 0.0030
421 GAMMA-GLUTAMYLTRANSFERASE INCREASED 67 0.0030
422 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 10 0.0030
423 RENAL FAILURE ACUTE 128 0.0030
424 BLOOD CREATININE INCREASED 195 0.0030
425 ORGAN FAILURE 12 0.0030
426 HEPATIC CYST 10 0.0029
427 RHABDOMYOLYSIS 122 0.0029
428 HYPERURICAEMIA 12 0.0029
429 CARDIOTOXICITY 26 0.0029
430 DRUG LEVEL BELOW THERAPEUTIC 16 0.0029
431 NECROSIS 16 0.0029
432 ACUTE PULMONARY OEDEMA 16 0.0028
433 INTESTINAL PERFORATION 32 0.0028
434 NEUTROPENIA 387 0.0028
435 STAPHYLOCOCCAL SEPSIS 14 0.0028
436 TRANSAMINASES INCREASED 63 0.0028
437 POLYMYALGIA RHEUMATICA 9 0.0028
438 RENAL IMPAIRMENT 238 0.0028
439 PULMONARY TOXICITY 20 0.0028
440 RHINOVIRUS INFECTION 11 0.0028
441 FORCED EXPIRATORY VOLUME DECREASED 8 0.0028
442 ACUTE MYELOID LEUKAEMIA 44 0.0028
443 ABDOMINAL TENDERNESS 14 0.0028
444 HEPATIC FUNCTION ABNORMAL 105 0.0028
445 LIVER INJURY 69 0.0028
446 COVID-19 PNEUMONIA 33 0.0028
447 DEVICE RELATED INFECTION 43 0.0028
448 LYMPHOCYTE COUNT DECREASED 49 0.0028
449 PATENT DUCTUS ARTERIOSUS 11 0.0028
450 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 152 0.0028
451 PYELONEPHRITIS 24 0.0028
452 C-REACTIVE PROTEIN INCREASED 100 0.0027
453 LACTIC ACIDOSIS 89 0.0027
454 SCOLIOSIS 17 0.0027
455 NEUTROPHIL COUNT INCREASED 28 0.0027
456 PULSE ABSENT 13 0.0027
457 IMMUNOSUPPRESSION 24 0.0027
458 PARADOXICAL DRUG REACTION 10 0.0027
459 CYTOMEGALOVIRUS VIRAEMIA 12 0.0027
460 ERYTHEMA MULTIFORME 25 0.0027
461 CEREBRAL HAEMATOMA 9 0.0027
462 ELECTROLYTE IMBALANCE 31 0.0027
463 MYOPATHY 23 0.0027
464 BLOOD ALBUMIN DECREASED 21 0.0026
465 SPLENOMEGALY 31 0.0026
466 PYREXIA 914 0.0026
467 DERMATITIS BULLOUS 19 0.0026
468 ENCEPHALITIS 18 0.0026
469 FIBROSIS 8 0.0026
470 MICTURITION DISORDER 9 0.0026
471 BRAIN INJURY 26 0.0026
472 BRAIN DEATH 8 0.0026
473 CARDIOGENIC SHOCK 37 0.0026
474 DYSPHORIA 13 0.0026
475 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 13 0.0026
476 ELECTROCARDIOGRAM QT PROLONGED 92 0.0026
477 PAPULE 18 0.0026
478 THROMBOTIC THROMBOCYTOPENIC PURPURA 9 0.0026
479 CARDIAC FAILURE ACUTE 17 0.0025
480 DUODENAL ULCER 18 0.0025
481 HEPATIC LESION 11 0.0025
482 ATRIOVENTRICULAR BLOCK FIRST DEGREE 11 0.0025
483 BLOOD ALKALINE PHOSPHATASE INCREASED 63 0.0025
484 CYTOPENIA 31 0.0025
485 CACHEXIA 13 0.0025
486 BLADDER PAIN 8 0.0025
487 URINE OUTPUT DECREASED 22 0.0025
488 VENTRICULAR TACHYCARDIA 41 0.0025
489 CYSTITIS HAEMORRHAGIC 10 0.0025
490 HYPOTHERMIA 25 0.0025
491 BACTERIAL INFECTION 46 0.0025
492 DRUG LEVEL DECREASED 25 0.0025
493 JAUNDICE 66 0.0025
494 PERIPHERAL ISCHAEMIA 10 0.0024
495 BLOOD BILIRUBIN INCREASED 66 0.0024
496 CARDIAC ARREST 200 0.0024
497 LEUKOENCEPHALOPATHY 9 0.0024
498 MYELOSUPPRESSION 87 0.0024
499 RED CELL DISTRIBUTION WIDTH INCREASED 10 0.0024
500 SKIN WARM 14 0.0024
501 GASTROINTESTINAL PERFORATION 10 0.0024
502 HAEMOPTYSIS 67 0.0024
503 BLOOD UREA INCREASED 40 0.0024
504 INTERSTITIAL LUNG DISEASE 115 0.0024
505 TONGUE OEDEMA 9 0.0024
506 ALANINE AMINOTRANSFERASE INCREASED 144 0.0023
507 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 12 0.0023
508 STREPTOCOCCAL INFECTION 13 0.0023
509 ADRENAL INSUFFICIENCY 28 0.0023
510 WOUND SECRETION 9 0.0023
511 HYPERREFLEXIA 8 0.0023
512 MELAENA 50 0.0023
513 SUBARACHNOID HAEMORRHAGE 23 0.0023
514 FIBRIN D DIMER INCREASED 8 0.0022
515 NEPHROPATHY 21 0.0022
516 CREATININE RENAL CLEARANCE DECREASED 9 0.0022
517 ANAPHYLACTIC REACTION 120 0.0022
518 VASCULITIS 25 0.0021
519 HEPATIC ENCEPHALOPATHY 20 0.0021
520 RESPIRATORY RATE INCREASED 19 0.0021
521 HYPOTENSION 429 0.0021
522 ASPARTATE AMINOTRANSFERASE INCREASED 113 0.0021
523 CHOLECYSTITIS ACUTE 12 0.0021
524 NEUTROPHILIA 12 0.0021
525 HAEMATURIA 72 0.0021
526 TRANSFUSION 22 0.0021
527 HYPERKALAEMIA 73 0.0021
528 BRONCHIECTASIS 14 0.0021
529 COLITIS 78 0.0021
530 RASH ERYTHEMATOUS 98 0.0020
531 WHITE BLOOD CELL COUNT INCREASED 78 0.0020
532 ENTERITIS 13 0.0020
533 BLOOD LACTATE DEHYDROGENASE INCREASED 32 0.0020
534 CHOLECYSTITIS 24 0.0020
535 CEREBRAL ATROPHY 8 0.0020
536 PROTHROMBIN TIME PROLONGED 12 0.0020
537 AZOTAEMIA 8 0.0020
538 CANDIDIASIS 8 0.0020
539 GENERALISED TONIC-CLONIC SEIZURE 33 0.0020
540 CORONARY ARTERY STENOSIS 10 0.0020
541 BRAIN OEDEMA 25 0.0020
542 CYANOSIS 31 0.0020
543 MALNUTRITION 22 0.0020
544 MOTOR DYSFUNCTION 20 0.0020
545 LEFT VENTRICULAR DYSFUNCTION 13 0.0019
546 NEUROLEPTIC MALIGNANT SYNDROME 23 0.0019
547 ILEUS 24 0.0019
548 CELLULITIS 97 0.0019
549 SECOND PRIMARY MALIGNANCY 16 0.0019
550 DEPRESSED LEVEL OF CONSCIOUSNESS 76 0.0019
551 EPSTEIN-BARR VIRUS INFECTION 12 0.0019
552 ORAL CANDIDIASIS 25 0.0019
553 HEPATIC STEATOSIS 35 0.0019
554 HYPERTRIGLYCERIDAEMIA 11 0.0019
555 GLOMERULAR FILTRATION RATE DECREASED 23 0.0019
556 TACHYCARDIA 166 0.0019
557 HEPATIC ENZYME INCREASED 127 0.0019
558 SINUS BRADYCARDIA 18 0.0019
559 ANAPHYLACTIC SHOCK 48 0.0019
560 RIGHT VENTRICULAR FAILURE 13 0.0019
561 HEPATITIS ACUTE 12 0.0018
562 RENAL FAILURE 245 0.0018
563 NORMAL NEWBORN 10 0.0018
564 FACE OEDEMA 31 0.0018
565 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 10 0.0018
566 MENTAL STATUS CHANGES 51 0.0018
567 DERMATITIS ALLERGIC 23 0.0018
568 FLANK PAIN 17 0.0018
569 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 16 0.0018
570 HYPOTONIA 18 0.0018
571 VENTRICULAR FIBRILLATION 20 0.0018
572 ACUTE MYOCARDIAL INFARCTION 53 0.0018
573 ATRIOVENTRICULAR BLOCK COMPLETE 12 0.0018
574 CARDIOMEGALY 22 0.0018
575 PERITONITIS 37 0.0018
576 COLITIS ISCHAEMIC 12 0.0018
577 PERICARDIAL EFFUSION 41 0.0018
578 UVEITIS 24 0.0018
579 ATRIAL FLUTTER 14 0.0018
580 INTERNATIONAL NORMALISED RATIO INCREASED 50 0.0018
581 NEPHROTIC SYNDROME 12 0.0017
582 ECCHYMOSIS 12 0.0017
583 SKIN LESION 48 0.0017
584 TONSILLITIS 9 0.0017
585 LIVER FUNCTION TEST INCREASED 37 0.0017
586 LIVER FUNCTION TEST ABNORMAL 50 0.0017
587 OCCUPATIONAL EXPOSURE TO PRODUCT 11 0.0017
588 PROCTALGIA 11 0.0017
589 TROPONIN INCREASED 13 0.0017
590 OBSTRUCTIVE AIRWAYS DISORDER 19 0.0017
591 LYMPHADENOPATHY 60 0.0017
592 SPUTUM DISCOLOURED 16 0.0017
593 MUSCLE RIGIDITY 20 0.0017
594 SUPRAVENTRICULAR TACHYCARDIA 16 0.0017
595 ELECTROCARDIOGRAM ABNORMAL 13 0.0017
596 HYDROCEPHALUS 9 0.0017
597 FOETAL GROWTH RESTRICTION 10 0.0016
598 PREMATURE DELIVERY 26 0.0016
599 TENDERNESS 17 0.0016
600 POSTOPERATIVE WOUND INFECTION 11 0.0016
601 THERAPY NON-RESPONDER 73 0.0016
602 ALTERED STATE OF CONSCIOUSNESS 35 0.0016
603 JOINT EFFUSION 11 0.0016
604 CARDIAC FAILURE 128 0.0016
605 HYPOMAGNESAEMIA 22 0.0016
606 NEUROLOGICAL SYMPTOM 9 0.0016
607 FUNGAL INFECTION 52 0.0016
608 UNRESPONSIVE TO STIMULI 40 0.0015
609 HYPOGLYCAEMIA 75 0.0015
610 TREATMENT FAILURE 128 0.0015
611 FOETAL DEATH 8 0.0015
612 BRONCHOSPASM 22 0.0015
613 CONDITION AGGRAVATED 466 0.0015
614 OXYGEN SATURATION DECREASED 86 0.0015
615 ATAXIA 18 0.0015
616 HYPOKINESIA 22 0.0015
617 BLISTER 85 0.0015
618 PRODUCT USE IN UNAPPROVED INDICATION 374 0.0015
619 GASTROENTERITIS 22 0.0015
620 ORAL DISORDER 11 0.0015
621 MOUTH HAEMORRHAGE 11 0.0015
622 BLOOD DISORDER 12 0.0015
623 RESPIRATORY TRACT INFECTION 39 0.0015
624 PNEUMONIA 478 0.0015
625 DECUBITUS ULCER 12 0.0015
626 BODY TEMPERATURE INCREASED 30 0.0015
627 LARYNGEAL OEDEMA 9 0.0015
628 ACUTE CORONARY SYNDROME 12 0.0014
629 EMBOLISM 12 0.0014
630 PULMONARY OEDEMA 64 0.0014
631 DIFFUSE LARGE B-CELL LYMPHOMA 11 0.0014
632 HYPOCALCAEMIA 27 0.0014
633 SKIN REACTION 20 0.0014
634 RESPIRATORY ARREST 39 0.0014
635 EPILEPSY 43 0.0014
636 SMALL INTESTINAL OBSTRUCTION 17 0.0014
637 OSTEOMYELITIS 25 0.0014
638 BRADYCARDIA 73 0.0014
639 CEREBRAL HAEMORRHAGE 49 0.0014
640 HYPOVOLAEMIA 8 0.0014
641 GENERAL PHYSICAL HEALTH DETERIORATION 158 0.0014
642 ANAEMIA 260 0.0014
643 HYPERCHLORHYDRIA 8 0.0014
644 ARTERIOSCLEROSIS CORONARY ARTERY 9 0.0014
645 LOWER GASTROINTESTINAL HAEMORRHAGE 10 0.0014
646 GASTROINTESTINAL HAEMORRHAGE 113 0.0014
647 PLATELET COUNT DECREASED 144 0.0013
648 VENTRICULAR EXTRASYSTOLES 14 0.0013
649 CHILLS 158 0.0013
650 HAEMORRHAGE INTRACRANIAL 20 0.0013
651 MYOSITIS 12 0.0013
652 BLOOD CALCIUM DECREASED 15 0.0013
653 INTRAOCULAR PRESSURE INCREASED 17 0.0013
654 LUNG DISORDER 64 0.0013
655 NEUTROPHIL COUNT DECREASED 53 0.0013
656 PULMONARY CONGESTION 17 0.0013
657 APPENDICITIS 12 0.0013
658 CHROMATURIA 29 0.0013
659 ATRIAL FIBRILLATION 125 0.0013
660 MOUTH ULCERATION 27 0.0013
661 GASTROINTESTINAL INFLAMMATION 10 0.0013
662 ARTERIOSCLEROSIS 12 0.0013
663 MUSCLE ATROPHY 16 0.0013
664 POLYNEUROPATHY 15 0.0013
665 GRIP STRENGTH DECREASED 11 0.0012
666 HAEMOGLOBIN DECREASED 127 0.0012
667 HYPERGLYCAEMIA 45 0.0012
668 HYPOGAMMAGLOBULINAEMIA 8 0.0012
669 OFF LABEL USE 1064 0.0012
670 PROTEINURIA 23 0.0012
671 PULMONARY FIBROSIS 23 0.0012
672 RESPIRATORY DISORDER 35 0.0012
673 FLUID OVERLOAD 17 0.0012
674 SKIN INFECTION 13 0.0012
675 CONFUSIONAL STATE 187 0.0012
676 COMA 55 0.0012
677 DRUG INEFFECTIVE 1522 0.0012
678 DIALYSIS 16 0.0011
679 HEMIPARESIS 19 0.0011
680 SECRETION DISCHARGE 14 0.0011
681 PANCREATITIS ACUTE 25 0.0011
682 CARDIO-RESPIRATORY ARREST 46 0.0011
683 OESOPHAGITIS 12 0.0011
684 INFECTION 158 0.0011
685 HALLUCINATION, VISUAL 23 0.0011
686 INFLAMMATION 56 0.0011
687 ANGIOEDEMA 48 0.0011
688 HYPONATRAEMIA 61 0.0011
689 ATRIAL SEPTAL DEFECT 9 0.0011
690 TOXICITY TO VARIOUS AGENTS 181 0.0011
691 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 11 0.0011
692 OEDEMA 58 0.0011
693 SKIN PLAQUE 9 0.0011
694 MATERNAL EXPOSURE DURING PREGNANCY 94 0.0011
695 HYPERCALCAEMIA 13 0.0011
696 RECTAL HAEMORRHAGE 45 0.0010
697 LIVER DISORDER 46 0.0010
698 LUNG INFECTION 16 0.0010
699 LOWER RESPIRATORY TRACT INFECTION 46 0.0010
700 PULMONARY HYPERTENSION 21 0.0010
701 PREMATURE BABY 30 0.0010
702 AGITATION 73 0.0010
703 FISTULA 11 0.0010
704 OVARIAN CANCER 9 0.0010
705 NERVE COMPRESSION 9 0.0010
706 HAEMATOMA 25 0.0010
707 DIARRHOEA HAEMORRHAGIC 9 0.0010
708 THERAPY PARTIAL RESPONDER 15 0.0010
709 HAEMATOCRIT DECREASED 19 0.0010
710 NEOPLASM 11 0.0010
711 RESTLESSNESS 35 0.0010
712 DYSPHAGIA 90 0.0009
713 ABDOMINAL PAIN 219 0.0009
714 RASH PRURITIC 51 0.0009
715 PULMONARY MASS 14 0.0009
716 MYDRIASIS 12 0.0009
717 HYPOAESTHESIA ORAL 14 0.0009
718 RASH GENERALISED 24 0.0009
719 DISORIENTATION 36 0.0009
720 HAEMATEMESIS 23 0.0009
721 ISCHAEMIC STROKE 16 0.0009
722 RASH 390 0.0009
723 PERICARDITIS 15 0.0009
724 GASTROINTESTINAL INFECTION 8 0.0009
725 EMPHYSEMA 9 0.0009
726 UPPER RESPIRATORY TRACT INFECTION 41 0.0009
727 END STAGE RENAL DISEASE 16 0.0009
728 WHITE BLOOD CELL COUNT DECREASED 95 0.0009
729 MYOCARDITIS 10 0.0009
730 IMMUNODEFICIENCY 13 0.0009
731 ORAL HERPES 17 0.0009
732 BLOOD CREATINE PHOSPHOKINASE INCREASED 25 0.0009
733 DIVERTICULITIS 24 0.0009
734 DERMATITIS 18 0.0009
735 HAEMATOTOXICITY 8 0.0008
736 RENAL INJURY 25 0.0008
737 SUBDURAL HAEMATOMA 12 0.0008
738 HYPERLIPIDAEMIA 10 0.0008
739 FAECES DISCOLOURED 18 0.0008
740 DISEASE PROGRESSION 98 0.0008
741 SKIN LACERATION 9 0.0008
742 CONTRAINDICATED PRODUCT ADMINISTERED 25 0.0008
743 EAR PAIN 16 0.0008
744 ASPIRATION 9 0.0008
745 NO THERAPEUTIC RESPONSE 10 0.0008
746 SEIZURE 94 0.0008
747 COVID-19 142 0.0008
748 ANGINA PECTORIS 23 0.0008
749 NERVOUS SYSTEM DISORDER 25 0.0008
750 DYSARTHRIA 30 0.0008
751 MYOCARDIAL ISCHAEMIA 9 0.0008
752 HALLUCINATION 59 0.0008
753 LYMPHOMA 12 0.0008
754 PRODUCTIVE COUGH 37 0.0008
755 BLOOD PRESSURE SYSTOLIC INCREASED 15 0.0008
756 NODULE 10 0.0008
757 URINARY TRACT INFECTION 130 0.0008
758 ARRHYTHMIA 36 0.0008
759 CONJUNCTIVITIS 14 0.0008
760 HEPATIC CIRRHOSIS 14 0.0007
761 CARDIOMYOPATHY 11 0.0007
762 DYSPNOEA 418 0.0007
763 CEREBRAL INFARCTION 18 0.0007
764 SKIN ULCER 19 0.0007
765 RESPIRATORY DEPRESSION 9 0.0007
766 DRUG TOXICITY 10 0.0007
767 INJECTION SITE EXTRAVASATION 9 0.0007
768 STOMATITIS 44 0.0007
769 INFUSION RELATED REACTION 48 0.0007
770 VISUAL ACUITY REDUCED 24 0.0007
771 ERYTHEMA 148 0.0007
772 DIARRHOEA 464 0.0007
773 HYPERSENSITIVITY 133 0.0007
774 DYSURIA 26 0.0007
775 OEDEMA PERIPHERAL 85 0.0007
776 APHASIA 21 0.0007
777 LETHARGY 40 0.0007
778 BLOOD URINE PRESENT 13 0.0007
779 WHEEZING 40 0.0007
780 BLOOD IRON DECREASED 8 0.0007
781 PULMONARY EMBOLISM 64 0.0007
782 ORAL PAIN 15 0.0007
783 PRODUCT USE ISSUE 124 0.0007
784 EJECTION FRACTION DECREASED 10 0.0006
785 HAEMATOCHEZIA 35 0.0006
786 RASH MACULAR 22 0.0006
787 SKIN EXFOLIATION 53 0.0006
788 CORONARY ARTERY DISEASE 19 0.0006
789 CHEST DISCOMFORT 64 0.0006
790 ABDOMINAL DISTENSION 65 0.0006
791 MYELODYSPLASTIC SYNDROME 9 0.0006
792 LOCALISED INFECTION 15 0.0006
793 BLOOD POTASSIUM INCREASED 10 0.0006
794 HYPERTENSION 130 0.0006
795 PROCEDURAL PAIN 17 0.0006
796 DISEASE RECURRENCE 29 0.0006
797 SINUS DISORDER 12 0.0006
798 PHOTOSENSITIVITY REACTION 10 0.0006
799 NEOPLASM PROGRESSION 21 0.0006
800 BLOOD PRESSURE DECREASED 40 0.0006
801 BLOOD POTASSIUM DECREASED 18 0.0006
802 RED BLOOD CELL COUNT DECREASED 17 0.0006
803 HYPOPHAGIA 15 0.0006
804 INTESTINAL OBSTRUCTION 22 0.0006
805 VOMITING 273 0.0006
806 GASTRIC ULCER 11 0.0006
807 INCREASED APPETITE 11 0.0006
808 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 30 0.0006
809 HAEMORRHAGE 60 0.0006
810 COORDINATION ABNORMAL 8 0.0006
811 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
812 MUSCLE TWITCHING 13 0.0006
813 COUGH 157 0.0006
814 PRURITUS 213 0.0006
815 PRODUCT PRESCRIBING ISSUE 12 0.0006
816 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
817 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 16 0.0005
818 SWOLLEN TONGUE 17 0.0005
819 PRODUCT ADMINISTRATION ERROR 11 0.0005
820 HYPERHIDROSIS 70 0.0005
821 FOETAL EXPOSURE DURING PREGNANCY 44 0.0005
822 SKIN DISORDER 18 0.0005
823 FEELING COLD 15 0.0005
824 INTENTIONAL PRODUCT USE ISSUE 47 0.0005
825 GASTROINTESTINAL DISORDER 48 0.0005
826 DEAFNESS 14 0.0005
827 NEURALGIA 13 0.0005
828 PANCREATITIS 28 0.0005
829 DRUG INTOLERANCE 51 0.0005
830 MUSCULOSKELETAL DISORDER 10 0.0005
831 DEEP VEIN THROMBOSIS 34 0.0005
832 EPISTAXIS 39 0.0005
833 DYSTONIA 10 0.0005
834 EXPOSURE DURING PREGNANCY 32 0.0005
835 HEART RATE INCREASED 51 0.0005
836 PALLOR 14 0.0005
837 DECREASED APPETITE 119 0.0005
838 MUSCULAR WEAKNESS 58 0.0005
839 LABORATORY TEST ABNORMAL 15 0.0005
840 BLOOD PRESSURE ABNORMAL 10 0.0005
841 DEHYDRATION 67 0.0005
842 MALIGNANT NEOPLASM PROGRESSION 51 0.0005
843 TOOTHACHE 9 0.0005
844 ECZEMA 26 0.0005
845 CHEST PAIN 92 0.0005
846 MENTAL DISORDER 21 0.0005
847 LIP SWELLING 16 0.0005
848 EYE PAIN 27 0.0005
849 TYPE 2 DIABETES MELLITUS 16 0.0005
850 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
851 CARDIAC FAILURE CONGESTIVE 37 0.0005
852 LOSS OF CONSCIOUSNESS 59 0.0005
853 NEPHROLITHIASIS 21 0.0005
854 GASTRITIS 12 0.0005
855 CHRONIC KIDNEY DISEASE 34 0.0004
856 EXTRAPYRAMIDAL DISORDER 11 0.0004
857 ACCIDENTAL OVERDOSE 16 0.0004
858 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 31 0.0004
859 HERPES ZOSTER 25 0.0004
860 BRONCHITIS 32 0.0004
861 OROPHARYNGEAL PAIN 40 0.0004
862 URTICARIA 72 0.0004
863 JOINT INJURY 9 0.0004
864 TREATMENT NONCOMPLIANCE 23 0.0004
865 URINARY RETENTION 14 0.0004
866 TREMOR 69 0.0004
867 MALAISE 182 0.0004
868 PRESYNCOPE 10 0.0004
869 CYSTITIS 13 0.0004
870 RHINORRHOEA 26 0.0004
871 RASH PAPULAR 9 0.0004
872 SNEEZING 9 0.0004
873 NEUROPATHY PERIPHERAL 38 0.0004
874 SWELLING FACE 26 0.0004
875 FULL BLOOD COUNT DECREASED 8 0.0004
876 ABDOMINAL PAIN LOWER 10 0.0004
877 ASTHENIA 145 0.0004
878 THROMBOSIS 31 0.0004
879 SEDATION 10 0.0004
880 SYNCOPE 38 0.0004
881 MEDICATION ERROR 21 0.0004
882 OSTEOARTHRITIS 16 0.0004
883 MOVEMENT DISORDER 12 0.0004
884 DYSPNOEA EXERTIONAL 14 0.0004
885 OSTEONECROSIS 12 0.0004
886 NECK PAIN 20 0.0004
887 THERAPEUTIC PRODUCT EFFECT DECREASED 16 0.0004
888 INJURY 25 0.0004
889 CONVULSION 20 0.0003
890 THERAPEUTIC RESPONSE DECREASED 21 0.0003
891 INFLUENZA 38 0.0003
892 AGGRESSION 17 0.0003
893 SOMNOLENCE 68 0.0003
894 CHOLELITHIASIS 11 0.0003
895 NAUSEA 263 0.0003
896 BLOOD PRESSURE INCREASED 50 0.0003
897 DYSPHONIA 19 0.0003
898 SPEECH DISORDER 17 0.0003
899 WEIGHT DECREASED 90 0.0003
900 PAIN IN JAW 9 0.0003
901 CONSTIPATION 69 0.0003
902 FLUID RETENTION 16 0.0003
903 HYPOTHYROIDISM 10 0.0003
904 OVERDOSE 65 0.0003
905 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
906 ABDOMINAL PAIN UPPER 61 0.0003
907 INTENTIONAL OVERDOSE 19 0.0003
908 EYE SWELLING 11 0.0003
909 FLUSHING 30 0.0003
910 DRUG ADMINISTRATION ERROR 9 0.0003
911 PARAESTHESIA 45 0.0003
912 DRUG WITHDRAWAL SYNDROME 25 0.0003
913 BACK PAIN 66 0.0003
914 SKIN DISCOLOURATION 13 0.0003
915 PLASMA CELL MYELOMA 11 0.0003
916 COGNITIVE DISORDER 13 0.0003
917 ABORTION SPONTANEOUS 11 0.0003
918 COLITIS ULCERATIVE 12 0.0003
919 PALPITATIONS 31 0.0003
920 RENAL DISORDER 12 0.0003
921 JOINT SWELLING 31 0.0003
922 MUSCULOSKELETAL STIFFNESS 22 0.0003
923 PAIN 152 0.0002
924 PANIC ATTACK 9 0.0002
925 SWELLING 23 0.0002
926 IMPAIRED HEALING 8 0.0002
927 BURNING SENSATION 17 0.0002
928 DISTURBANCE IN ATTENTION 13 0.0002
929 DEATH 207 0.0002
930 NASAL CONGESTION 14 0.0002
931 VISUAL IMPAIRMENT 29 0.0002
932 DYSPEPSIA 23 0.0002
933 OCULAR HYPERAEMIA 11 0.0002
934 INFLUENZA LIKE ILLNESS 19 0.0002
935 RHEUMATOID ARTHRITIS 26 0.0002
936 INTENTIONAL PRODUCT MISUSE 20 0.0002
937 PERIPHERAL SWELLING 35 0.0002
938 ABDOMINAL DISCOMFORT 38 0.0002
939 SINUSITIS 23 0.0002
940 THROAT IRRITATION 10 0.0002
941 ARTHRALGIA 91 0.0002
942 MYALGIA 37 0.0002
943 POLLAKIURIA 9 0.0002
944 DISCOMFORT 13 0.0002
945 FLATULENCE 12 0.0002
946 PAIN IN EXTREMITY 62 0.0002
947 FALL 70 0.0002
948 DIABETES MELLITUS 16 0.0002
949 HYPOACUSIS 9 0.0002
950 GAIT DISTURBANCE 40 0.0002
951 MYOCARDIAL INFARCTION 36 0.0002
952 WEIGHT INCREASED 46 0.0002
953 HYPOAESTHESIA 30 0.0002
954 FATIGUE 156 0.0002
955 BALANCE DISORDER 17 0.0002
956 FEELING HOT 12 0.0002
957 THERAPY CESSATION 10 0.0002
958 CEREBROVASCULAR ACCIDENT 32 0.0002
959 DEPRESSION 42 0.0002
960 MUSCULOSKELETAL PAIN 9 0.0002
961 MOBILITY DECREASED 12 0.0002
962 MUSCLE SPASMS 30 0.0002
963 DRY MOUTH 13 0.0002
964 UNEVALUABLE EVENT 12 0.0002
965 ADVERSE DRUG REACTION 14 0.0002
966 ILLNESS 16 0.0002
967 NO ADVERSE EVENT 28 0.0002
968 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
969 VERTIGO 9 0.0001
970 HEADACHE 92 0.0001
971 ARTHROPATHY 8 0.0001
972 SKIN BURNING SENSATION 10 0.0001
973 EMOTIONAL DISTRESS 16 0.0001
974 INCORRECT DOSE ADMINISTERED 30 0.0001
975 DIZZINESS 65 0.0001
976 BLOOD GLUCOSE INCREASED 24 0.0001
977 HOT FLUSH 9 0.0001
978 MIGRAINE 11 0.0001
979 ASTHMA 13 0.0001
980 ALOPECIA 22 0.0001
981 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 20 0.0001
982 ARTHRITIS 8 0.0001
983 CONTUSION 9 0.0001
984 NASOPHARYNGITIS 17 0.0001
985 ANXIETY 26 0.0001
986 INSOMNIA 24 0.0001
987 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
988 HOSPITALISATION 12 0.0001
989 DRUG DEPENDENCE 12 0.0001
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
991 VISION BLURRED 10 0.0001
992 PSORIASIS 9 0.0001
993 DRY SKIN 8 0.0001
994 PRODUCT DOSE OMISSION ISSUE 17 0.0001
995 FEELING ABNORMAL 10 0.0000
996 INJECTION SITE PAIN 10 0.0000